Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ammonia Chloramine
2. Monochloramine
1. Monochloramine
2. Chloramide
3. 10599-90-3
4. Monochloroamine
5. Chloroamine
6. Monochloroammonia
7. Nh2cl
8. Kw8k411a1p
9. Monochloramide
10. Chloramine, Mono-
11. Ccris 4022
12. Chloramine (inorganic Compound)
13. Hsdb 4293
14. Einecs 234-217-9
15. Cloroamonio
16. Unii-kw8k411a1p
17. Chlorinated Water (chloramine)
18. Chloramine [hsdb]
19. Chloramine [iarc]
20. Ec 234-217-9
21. Dtxsid8023842
22. Chebi:82415
23. Dtxsid00721369
24. Pubchem_57347134
25. Amy37006
26. Akos015904329
27. 12190-75-9
28. Ft-0623594
29. C19359
30. Q409375
| Molecular Weight | 51.47 g/mol |
|---|---|
| Molecular Formula | ClH2N |
| XLogP3 | 0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 50.9875768 g/mol |
| Monoisotopic Mass | 50.9875768 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 2 |
| Formal Charge | 0 |
| Complexity | 2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Male Sprague-Dawley rats (220-240 g) were given 1.1 mg per animal [36Cl]-labelled chloramine [NH2 36Cl] orally as 3 mL of solution containing 370 mg/L chloramine. The peak plasma concentration of 36Cl (10.3 ug/L) was reached 8 hr after dosing, and the absorption and elimination half-lives were 2.5 hr and 38.8 hr, respectively. The distribution of radioactivity was highest in plasma and lowest in fat. Approximately 25% and 2% of the administered dose of radiolabelled chloramine was excreted in the urine and feces, respectively, during 120 hr of treatment. Only 0.35% of the administered dose of monochloramine was present in plasma as [36Cl] chloride 120 hr after treatment. No evidence for enzymatic intervention in the metabolism of monochloramine was presented.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V84 303 (2004)
The effect of 15 uM monochloramine as hepatic function was investigated in isolated perfused male Sprague-Dawley rat liver. The uptake of monochloramine averaged 98%. Approximately 0.7% of the amount taken up by the liver was reduced by glutathione (GSH) and appeared in the bile in the form of GSH disulfide.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V84 303 (2004)
Male Sprague-Dawley rats (220-240 g) were given 1.1 mg per animal [36Cl]-labelled chloramine [NH2 36Cl] orally as 3 mL of solution containing 370 mg/L chloramine. ...The absorption and elimination half-lives were 2.5 hr and 38.8 hr, respectively.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V84 303 (2004)
On dissolution of the chloramines in the epithelial lining fluid, hypochlorous acid, ammonia, and oxygen-radicals are generated, all of which act as irritants. /Chloramines/
Goldfrank, L.R. (ed). Goldfrank's Toxicologic Emergencies. 7th Edition McGraw-Hill New York, New York 2002., p. 1457
ABOUT THIS PAGE
A Chloramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chloramine, including repackagers and relabelers. The FDA regulates Chloramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chloramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chloramine supplier is an individual or a company that provides Chloramine active pharmaceutical ingredient (API) or Chloramine finished formulations upon request. The Chloramine suppliers may include Chloramine API manufacturers, exporters, distributors and traders.
Chloramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chloramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chloramine GMP manufacturer or Chloramine GMP API supplier for your needs.
A Chloramine CoA (Certificate of Analysis) is a formal document that attests to Chloramine's compliance with Chloramine specifications and serves as a tool for batch-level quality control.
Chloramine CoA mostly includes findings from lab analyses of a specific batch. For each Chloramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chloramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Chloramine EP), Chloramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chloramine USP).
LOOKING FOR A SUPPLIER?
